Cefotaxime
Approved
Approval ID
8efe3bd0-c43a-2bd6-e053-2a95a90a92fa
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 13, 2023
Manufacturers
FDA
SteriMax Inc.
DUNS: 251574851
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
cefotaxime injection
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code21586-012
Product Classification
G
Generic Name
cefotaxime injection
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateAugust 1, 2019
FDA Product Classification
INGREDIENTS (1)
CEFOTAXIME SODIUMActive
Quantity: 2 g in 1 1
Code: 258J72S7TZ
Classification: ACTIM
cefotaxime injection
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code21586-011
Product Classification
G
Generic Name
cefotaxime injection
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateAugust 1, 2019
FDA Product Classification
INGREDIENTS (1)
CEFOTAXIME SODIUMActive
Quantity: 1 g in 1 1
Code: 258J72S7TZ
Classification: ACTIM